Skip to content
★ Sign in to follow
EN

Eva Nilsagård

Hansa Biopharma AB
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€40k
▼ Sales (0 ops.)
—

Latest filing published 17 Dec 2019 for Hansa Biopharma AB, €20k.

Filing timeline

BuySale
Eva Nilsagård

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Eva Nilsagård: trading record in brief

Eva Nilsagård is a declared insider of Hansa Biopharma AB, with filings sourced from Finansinspektionen. In total, 2 filings cover trades dated from 16 December 2019 to 17 December 2019.

Purchases make up the whole of the open-market record (2 purchases, €40k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

Most recently, on 17 December 2019, the filings show an open-market purchase worth €20k in Hansa Biopharma AB. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Eva Nilsagård

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    Styrelseledamot/suppleantExecutivesHansa Biopharma AB
    206,340 SEK30FI-SE
    3,000 shares@ SEK 68.7850.0% of flowAktieISIN SE0002148817FI:csv-e54f3bd38f23bdfaad24
    Canonical exit: 16 Mar 2020 (T+90)
  • ▲
    Styrelseledamot/suppleantExecutivesHansa Biopharma AB
    206,340 SEK30FI-SE
    3,000 shares@ SEK 68.7850.0% of flowAktieISIN SE0002148817FI:csv-4350325a5c4b489f6a65
    Canonical exit: 15 Mar 2020 (T+90)

2 of 2 declarations